Investigation of SGLT2 inhibitors for normal glucose tolerance
Not Applicable
- Conditions
- normal glucose tolerance
- Registration Number
- JPRN-UMIN000013747
- Lead Sponsor
- Dianetes and Endocrinolohgy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1) Type 1 DM (including SPIDDM) 2) Allergy for SGLT2 or Ipragliflozin 3) severe liver dysfunction 4) severe renal dysfunction 5) severe cardiac dysfunction 6) less than 20 years or over 61 years 7) pregnancy or breast feeding 8) mental retardation or dementia 9) systematic steroid administered 10) other inappropriate persons judged by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method parameter of insulin secretion(Insulinogenic index, HOMA-beta, AUC-IRI) parameter ofinsulin sensitivity (HOMA-R, Composite indexGIR)
- Secondary Outcome Measures
Name Time Method